BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gao T, Ren Y, Li S, Lu X, Lei H. Immune response induced by oral administration with a Saccharomyces cerevisiae-based SARS-CoV-2 vaccine in mice. Microb Cell Fact 2021;20:95. [PMID: 33952256 DOI: 10.1186/s12934-021-01584-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Deng Y, Li J, Sun C, Chi H, Luo D, Wang R, Qiu H, Zhang Y, Wu M, Zhang X, Huang X, Xie L, Qin C. Rational Development of a Polysaccharide-Protein-Conjugated Nanoparticle Vaccine Against SARS-CoV-2 Variants and Streptococcus pneumoniae. Adv Mater 2022;34:e2200443. [PMID: 35332581 DOI: 10.1002/adma.202200443] [Reference Citation Analysis]
2 Chatterjee B, Thakur SS. Diverse vaccine platforms safeguarding against SARS-CoV-2 and its variants. Expert Rev Vaccines 2021. [PMID: 34697980 DOI: 10.1080/14760584.2022.1997601] [Reference Citation Analysis]
3 Goh S, Kolakowski J, Holder A, Pfuhl M, Ngugi D, Ballingall K, Tombacz K, Werling D. Development of a Potential Yeast-Based Vaccine Platform for Theileria parva Infection in Cattle. Front Immunol 2021;12:674484. [PMID: 34305904 DOI: 10.3389/fimmu.2021.674484] [Reference Citation Analysis]
4 Jouned MA, Kager J, Herwig C, Barz T. Event driven modelling for the accurate identification of metabolic switches in fed-batch culture of S. cerevisiae. Biochemical Engineering Journal 2022. [DOI: 10.1016/j.bej.2022.108345] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Kulagina N, Besseau S, Godon C, Goldman GH, Papon N, Courdavault V. Yeasts as Biopharmaceutical Production Platforms. Front Fungal Biol 2021;2:733492. [DOI: 10.3389/ffunb.2021.733492] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Chu KB, Kang HJ, Yoon KW, Lee HA, Moon EK, Han BK, Quan FS. Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains. Vaccines (Basel) 2021;9:920. [PMID: 34452044 DOI: 10.3390/vaccines9080920] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Zhang L, Yao L, Guo Y, Li X, Ma L, Sun R, Han X, Liu J, Huang J. Oral SARS-CoV-2 Spike Protein Recombinant Yeast Candidate Prompts Specific Antibody and Gut Microbiota Reconstruction in Mice. Front Microbiol 2022;13:792532. [DOI: 10.3389/fmicb.2022.792532] [Reference Citation Analysis]
8 Cid R, Bolívar J. Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies. Biomolecules 2021;11:1072. [PMID: 34439738 DOI: 10.3390/biom11081072] [Reference Citation Analysis]
9 Chen T, Hsu M, Lee M, Chou C. Gastrointestinal Involvement in SARS-CoV-2 Infection. Viruses 2022;14:1188. [DOI: 10.3390/v14061188] [Reference Citation Analysis]